Paul Stolzmann
YOU?
Author Swipe
View article: Association of oropharyngeal cancer HPV status with diffusion-weighted MR imaging and FDG-PET parameters
Association of oropharyngeal cancer HPV status with diffusion-weighted MR imaging and FDG-PET parameters Open
Background: Human papilloma virus (HPV) infection is an important risk factor in oropharyngeal cancer. Several studies have analyzed the association of tumoral HPV status and different imaging parameters in FDG-PET/CT and magnetic resonanc…
View article: Supplementary Data from Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients
Supplementary Data from Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients Open
Supplementary data
View article: Supplementary Data from Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients
Supplementary Data from Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients Open
Supplementary data
View article: Data from Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients
Data from Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients Open
Purpose:Combination of immune checkpoint inhibitors with chemotherapy is under investigation for cancer treatment.Experimental Design:We studied the rationale of such a combination for treating mesothelioma, a disease with limited treatmen…
View article: Data from Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients
Data from Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients Open
Purpose:Combination of immune checkpoint inhibitors with chemotherapy is under investigation for cancer treatment.Experimental Design:We studied the rationale of such a combination for treating mesothelioma, a disease with limited treatmen…
View article: Prognostic value of O-(2-[<sup>18</sup>F]-fluoroethyl)-L-tyrosine PET in relapsing oligodendroglioma
Prognostic value of O-(2-[<sup>18</sup>F]-fluoroethyl)-L-tyrosine PET in relapsing oligodendroglioma Open
FET-PET may provide added value for the prognostication of relapsing oligodendroglioma in addition to clinical parameters.
View article: Myocardial 18F-FDG Uptake Pattern for Cardiovascular Risk Stratification in Patients Undergoing Oncologic PET/CT
Myocardial 18F-FDG Uptake Pattern for Cardiovascular Risk Stratification in Patients Undergoing Oncologic PET/CT Open
Objective: Positron emission tomography/computed tomography with 18F-fluorodeoxy-glucose (18F-FDG-PET/CT) has become the standard staging modality in various tumor entities. Cancer patients frequently receive cardio-toxic therapies. Howeve…
Reference values of physiological 18F-FET uptake: Implications for brain tumor discrimination Open
Normal brain tissue demonstrates increased 18F-FET uptake compared to background tissue. Two distinct clusters have been identified, comprising venous structures and gray matter with a reference uptake of up to SUVmax of 2.99 and 2.33, res…
View article: The Monocle Sign in FDG-PET
The Monocle Sign in FDG-PET Open
We report three cases of unilateral 18 F-FDG uptake in the orbicularis oculi muscle in subjects with contralateral peripheral facial nerve palsy. We argue that this asymmetric uptake pattern in fact reflects lack of metabolism on the side …
View article: Value of PET/MRI for assessing tumor resectability in NSCLC—intra-individual comparison with PET/CT
Value of PET/MRI for assessing tumor resectability in NSCLC—intra-individual comparison with PET/CT Open
Objective: The purpose of this study was to compare the diagnostic accuracy of positron emission tomography (PET)/MRI with PET/CT for determining tumor resectability of non-small cell lung cancer (NSCLC). Methods: Sequential trimodality PE…
View article: Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients
Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients Open
Purpose: Combination of immune checkpoint inhibitors with chemotherapy is under investigation for cancer treatment. Experimental Design: We studied the rationale of such a combination for treating mesothelioma, a disease with limited treat…
View article: A patient with a history of breast cancer and multiple bone lesions: a case report
A patient with a history of breast cancer and multiple bone lesions: a case report Open
This case shows essential differential diagnosis in a patient with hypercalcemia and multiple bone lesions. Whenever multiple, fluorodeoxyglucose-avid bone lesions are found, malignancy and metabolic bone disease should both be included in…
View article: Clinical evaluation of a block sequential regularized expectation maximization reconstruction algorithm in 18F-FDG PET/CT studies
Clinical evaluation of a block sequential regularized expectation maximization reconstruction algorithm in 18F-FDG PET/CT studies Open
The BSREM reconstruction algorithm showed a relevant improvement compared with OSEM reconstruction in PET/CT studies in all evaluated categories. BSREM might be used in clinical routine in conjunction with TOF to achieve better/higher imag…
View article: <sup>18</sup>F-FDG PET/CT of Non–Small Cell Lung Carcinoma Under Neoadjuvant Chemotherapy: Background-Based Adaptive-Volume Metrics Outperform TLG and MTV in Predicting Histopathologic Response
<sup>18</sup>F-FDG PET/CT of Non–Small Cell Lung Carcinoma Under Neoadjuvant Chemotherapy: Background-Based Adaptive-Volume Metrics Outperform TLG and MTV in Predicting Histopathologic Response Open
PET volume metrics based on background-adaptive methods correlate better with histopathologic tumor regression score in NSCLC patients under neoadjuvant chemotherapy than algorithms and methods using a fixed threshold (42% SUVmax).